Home World News FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle Cell...

FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle Cell Lymphoma

May 27, 2026

Evidence for efficacy is based on the results from the BGB-11417-201 study

February 25, 2021

February 23, 2021

February 7, 2019

September 23, 2020